- Home
- JBGS vs OPK Comparison
JBGS vs OPK Comparison
Compare JBGS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBGS | OPK |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.3M | 921.2M |
| IPO Year | 2017 | 2011 |
Fundamental Metrics
Financial Performance| Metric | JBGS | OPK |
|---|---|---|
| Price | $14.49 | $1.29 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $15.00 | $1.60 |
| AVG Volume (30 Days) | 563.4K | ★ 2.3M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | ★ 4.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $498,598,000.00 | ★ $606,879,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.99 | $0.98 |
| 52 Week High | $24.30 | $1.60 |
Technical Indicators
Market Signals| Indicator | JBGS | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 44.49 | 71.83 |
| Support Level | $14.17 | $1.28 |
| Resistance Level | $16.07 | $1.42 |
| Average True Range (ATR) | 0.49 | 0.04 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 22.02 | 93.33 |
Price Performance
Historical ComparisonAbout JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.